| Autor: |
Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Roshal M; Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY., Fathi AT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ferrell PB; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Shaver AC; Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Frattini M; Celgene Corporation, Summit, NJ., Wang H; Agios Pharmaceuticals, Inc, Cambridge, MA., Hua L; Agios Pharmaceuticals, Inc, Cambridge, MA., Mu J; Agios Pharmaceuticals, Inc, Cambridge, MA., Choe S; Agios Pharmaceuticals, Inc, Cambridge, MA., Xu R; Agios Pharmaceuticals, Inc, Cambridge, MA., Almon C; Agios Pharmaceuticals, Inc, Cambridge, MA., Cooper M; Agios Pharmaceuticals, Inc, Cambridge, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; and., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.; Program in Cancer Biology and.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN. |
